Immunology Archives - El·lipse

Two hands with a white globe, collide

25.08.2021

Antibodies against SARS-CoV-2 remain stable seven months after the infection

12.07.2021

Immunity anniversary: antibodies against SARS-CoV-2 remain one year after infection

04.03.2021

Launched a clinical trial to prevent the side effects of COVID-19

02.12.2020

SARS-Cov-2 antibodies detected three months after the infection

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.

22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

Patients who received redemsivir had a 31% faster recovery time than those who received placebo. There was a 4-day reduction in hospital stay. | Picture by Francisco Avia.

08.05.2020

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

60-90% of the adult world population is infected by cytomegalovirus. It is a latent and asymptomatic infection. | Picture by Qimono from Pixabay.

27.02.2020

New protection biomarker against cytomegalovirus in kidney transplant patients

Researchers find that NFAT5 helps control the levels of interferons during the immune response. Image by allinonemovie from Pixabay.

12.02.2020

New key element to control interferons during the immune response

10.02.2020

“Being able to see the sea everyday from work is wonderful”

The IMIM organised a course on the latest advances on Immunotherapy. | Picture by Daniel Frank from Unsplash.

29.11.2019

Moving forward in immunotherapy research

The sleep-awake cycle is the classic example of circadian rhythm, but not the only one. Photo by Levi Guzman in Unsplash.

27.11.2019

Dancing to the circadian rhythms

A mathematical prediction of the spatial trajectory of T lymphocytes during an HIV infection, according to a recent study.

15.07.2019

T lymphocyte trajectories in HIV-infected lymph nodes